Additional data show that pharmacological inhibition of the other major H2S producing enzyme, 3-MST can also improve bioenergetic profile in DS cells [21] — although by a relatively smaller degree compared to the effect of CBS inhibition. This evidence concerns the gene CBS and Dravet syndrome.